NDA Raids Kampala Herbal Factory, Arrests Two Over Suspected Illegal Drug Production

By Swift Reporter 

The National Drug Authority (NDA) has intensified its enforcement efforts against illegal drug manufacturing, arresting two individuals during an operation at Grina Medicinal Foods Limited in Busega-Kibumbiro, Kampala.

The operation led to the recovery of several suspected unauthorized herbal products and production materials believed to have been manufactured and distributed without regulatory approval.

Among those arrested were the proprietor of the facility, Ssendegeya Marvin, and the company manager. The suspects are currently being held in police custody as investigations continue and preparations are made to have them produced before court.

According to NDA, preliminary findings indicate that Ssendegeya and his associates were allegedly involved in the production and sale of herbal medicines and toothpaste products that had not been authorized by the Authority.

During the operation, enforcement officers seized a wide range of products, including Sexual Powder Booster, Lemon Cough Drink, Pomegranate Fermented Blend marketed as Menstrual Ease, Sika Secret Oil, Ulcer Go products, Antiseptic Mouth Rinse, Lady Secret Finger Millet products, Digestive Cleanser, and Albizia Powder.

The team also recovered an unidentified liquid stored in two 10-litre jerrycans, alongside manufacturing equipment such as an electric mixer, a heat gun, printed labels, packaging materials, and patient information leaflets linked to the products.

The recovered materials included labels and packaging for Digestive Cleanser, Grina Lady’s Secret, Grina Ulcer Go, and Grina Brain Booster Tea products. NDA officials said the operation forms part of the Authority’s ongoing mandate to protect the public from potentially unsafe medicines and ensure that all health products available on the market meet established safety, quality, and regulatory standards.

The Authority has further warned manufacturers and distributors against producing or marketing medicines without proper authorization, emphasizing that such practices pose serious risks to public health and will attract legal action.